Your browser doesn't support javascript.
loading
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy.
Hong, Xin; Sullivan, Ryan J; Kalinich, Mark; Kwan, Tanya Todorova; Giobbie-Hurder, Anita; Pan, Shiwei; LiCausi, Joseph A; Milner, John D; Nieman, Linda T; Wittner, Ben S; Ho, Uyen; Chen, Tianqi; Kapur, Ravi; Lawrence, Donald P; Flaherty, Keith T; Sequist, Lecia V; Ramaswamy, Sridhar; Miyamoto, David T; Lawrence, Michael; Toner, Mehmet; Isselbacher, Kurt J; Maheswaran, Shyamala; Haber, Daniel A.
Afiliação
  • Hong X; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Sullivan RJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Kalinich M; Division of Hematology-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Kwan TT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Giobbie-Hurder A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Pan S; Division of Biostatistics, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.
  • LiCausi JA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Milner JD; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Nieman LT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Wittner BS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Ho U; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Chen T; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Kapur R; Division of Biostatistics, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.
  • Lawrence DP; Center for Bioengineering in Medicine, Massachusetts General Hospital and Shriners Hospital for Children, Harvard Medical School, Boston, MA 02114.
  • Flaherty KT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Sequist LV; Division of Hematology-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Ramaswamy S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Miyamoto DT; Division of Hematology-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Lawrence M; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Toner M; Division of Hematology-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Isselbacher KJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
  • Maheswaran S; Division of Hematology-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Haber DA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114.
Proc Natl Acad Sci U S A ; 115(10): 2467-2472, 2018 03 06.
Article em En | MEDLINE | ID: mdl-29453278

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Biomarcadores Tumorais / Antineoplásicos Imunológicos / Melanoma / Células Neoplásicas Circulantes Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Biomarcadores Tumorais / Antineoplásicos Imunológicos / Melanoma / Células Neoplásicas Circulantes Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article